English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduToday, the United States Preventive Services Task Force (USPSTF) finalized its recommendation to adapt the colorectal cancer (CRC) screening guidelines and lower the age to begin screening to 45 instead of 50. “Shifting current age-specific screening rates to five years…
Tag: Colon Cancer
Mental Health Support: Study Reveals Huge Need Amongst Colorectal Cancer Patients
This Mental Health Awareness Month, Fight Colorectal Cancer, is urging the clinician and patient communities to take mental health seriously and connect patients with resources.
Patient reactions to colorectal cancer estimated to become the leading cause of cancer-related deaths for those 20-49 by 2030
In a recent JAMA publication, researchers predict, “For the age group 20-49, colorectal cancer was estimated to become the leading cause of cancer-related deaths by 2030.” Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization, is committed to amplifying…
NYU Langone Seeks to Close the Gap in Colorectal Cancer Disparities with $2.2 Million Cohen Foundation Grant
NYU Langone Health will expand colorectal cancer screenings to address disease disparities in underserved communities with a $2.2 million grant from the Steven & Alexandra Cohen Foundation.
Rock Musicians Rufus Wainwright, Lisa Loeb, Tim Reynolds and More to Perform Free Virtual Concert for Colorectal Cancer Awareness
The American College of Gastroenterology Invites All to “Tune It Up: A Concert To Raise Awareness of Colorectal Cancer” Free Webstream Event Open to All on March 31, 2021 at 8:00 pm EDT
Baby Aspirin Linked to Lower Risk of Colorectal Cancer Death
Long-term, regular use of baby aspirin—at least 15 times per month—prior to a diagnosis of colorectal cancer (CRC) may reduce the risk of death from the disease by limiting the spread of cancerous tumors pre-diagnosis, according to a study led by Cedars-Sinai Cancer researchers.
GI OnDEMAND Announces Partnership with Ambry Genetics for Genetic Testing and Counseling Services
GI OnDEMAND®, gastroenterology’s leading multidisciplinary virtual integrated care platform today announced a partnership with Ambry Genetics®, a leading clinical genetic testing company, to integrate online genetic counseling and testing services into gastroenterology practices nationwide. This partnership addresses a critical clinical need for identifying hereditary GI cancer syndromes to help guide potentially life-altering health care decisions.
GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer the CARE (Comprehensive, Assessment, Risk, and Education) Program™ from Ambry Genetics.
American College of Gastroenterology Issues Updated Colorectal Cancer Screening Guidelines
The American College of Gastroenterology has issued updated evidence-based screening guidelines for colorectal cancer (CRC), including a new recommendation to begin CRC screening at age 45 for average risk adults. Key updates include recommendations for screening individuals with family history of CRC or polyps, guidance on the use of aspirin to reduce the risk of CRC, quality indicators for adenoma detection rate and colonoscopy withdrawal time, as well as suggestions about evidence-based interventions to boost screening rates, especially among African Americans. The authors distinguish between one-step screening tests, such as colonoscopy, and two-step screening tests that require colonoscopy, if positive, in order to complete the screening process.
The Medical Minute: Colonoscopy comes calling earlier under new screening guidelines
Evolving evidence shows screening tests should actually start at age 45 for people at average risk for colorectal cancer. Two Penn State Health doctors discuss new guidelines.
March is the Month to Get to the Bottom of Colorectal Cancer
Discussions about digestion and elimination can be embarrassing, so many people, young and old, tend to avoid them. But ignoring the topic and skipping colorectal cancer screening can lead to deadly results, experts say.
Colonoscopy: Yes, This is a Test
Colorectal cancer is the second leading cause of cancer death for both men and women, according to the Centers for Disease Control and Prevention (CDC), even though 90 percent of people who are diagnosed through early testing can be cured.
Putting the Spotlight on Colorectal Cancer Risk and Prevention during Colorectal Cancer Awareness Month
Colorectal Cancer Screening Saves Lives Colorectal cancer is the third most common cause of cancer related death for both men and women. However, if it is caught early, colorectal cancer has a 90% survival rate. This is why screening is…
UCLA expert available to discuss colorectal cancer screening prevention, more during Colorectal Cancer Awareness Month
Folasade May, MD, PhD, UCLA Health colon cancer prevention researcher and gastroenterologist, is available for interview on a variety of topics during colorectal cancer awareness month, including: Why it’s so important to not skip colorectal cancer screenings — even though…
Year or More Delay Between Abnormal, At-Home Screening and Colonoscopy Increases Cancer Risk
A new study by researchers at University of California San Diego School of Medicine found delayed time between abnormal stool-based screening and subsequent colonoscopy was associated with an increased risk of a cancer diagnosis and death from colorectal cancer.
Strange colon discovery explains racial disparities in colorectal cancer
The colons of African-Americans and people of European descent age differently, new research reveals, helping explain racial disparities in colorectal cancer – the cancer that killed beloved “Black Panther” star Chadwick Boseman.
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic
New combination therapy could help fight difficult-to-treat cancers with common mutations
UCLA scientists describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving proteins in a death grip. This combination of two small molecules has the potential to treat not only BRAF mutated melanoma but also additional aggressive subtypes of cancers, including melanoma, lung, pancreatic and colon cancers that harbor common mutations in cancer genes called RAS or NF1.
Fight Colorectal Cancer Issues Four New State Grants to Support Colorectal Cancer Policy Change
The nation’s largest colorectal cancer advocacy organization keeps fighting to lower the screening age and increase access in Kentucky, Nebraska, Rhode Island, and Texas.
Why Black women (and men) are dying of colorectal cancer at higher rates
Dr. Fola P. May is available to discuss the concern over young Black Americans dying of colorectal cancer, such as actor Natalie Desselle-Reid and Chadwick Boseman. “Until we address the lowest screening rates in the most disadvantaged communities in the…
Medicaid expansion may result in earlier diagnosis and improved access to treatment of colon cancer
The Affordable Care Act’s Medicaid expansion for low-income people appears to lead to earlier diagnosis of colon cancer, enhanced access to care, and improved surgical care for patients with this common cancer.
Surgical Techniques Using Heat May Contribute to Colon Cancer Recurrence in Mice
Article title: Hepatic thermal injury promotes colorectal cancer engraftment in C57/black 6 mice Authors: Alison L. Halpern, J. Gregory Fitz, Yuki Fujiwara, Jeniann Yi, Aimee L. Anderson, Yuwen Zhu, Richard D. Schulick, Karim C. El Kasmi, Carlton C. Barnett Jr.…
Colon cancer surgery performed by highly skilled surgeons improves long-term survival for patients
CHICAGO (October 30, 2020): Colon cancer patients achieve better five-year survival rates when the surgeons who treat them are rated as highly skilled, according to findings from what authors say is the first study to link a surgeon’s technical skills with improved long-term clinical outcomes. The study is published online in JAMA Oncology and virtually presented as part of the American College of Surgeons Commission on Cancer’s Annual Research Paper Competition.
Daily coffee consumption associated with improved survival in patients with metastatic colorectal cancer
In a large group of patients with metastatic colorectal cancer, consumption of a few cups of coffee a day was associated with longer survival and a lower risk of the cancer worsening, researchers at Dana-Farber Cancer Institute and other organizations report in a new study.
High-risk Patients for Colorectal Cancer Lack Knowledge About Colonoscopy
Many clinicians rely on self-reports from their high-risk patients about their need and proper interval for repeat surveillance colonoscopy. Researchers analyzed data over four years to explore the knowledge of these high-risk patients. Twenty-eight percent were unaware of either the need for a repeat colonoscopy or the proper surveillance interval. Of these, 16.6 percent were unaware of the proper three-year interval to obtain a follow-up surveillance colonoscopy. Also, 12 percent were not even aware that they required a follow-up surveillance colonoscopy.
Dropping it in The Mail: Best Practices Detailed For Mail-In Colon Cancer Screenings
DALLAS – Sept. 8, 2020 – A program that asks patients to mail in stool samples to screen for colon cancer is an effective way to expand screenings to underserved and underinsured communities and offers an alternative to in-person testing during the pandemic, according to a study conducted by UT Southwestern.
Cancer health and education providers stress importance of colorectal cancer awareness following death of “Black Panther” actor
Colorectal cancer is the second-leading cause of cancer-related deaths in men and the third-leading cause of cancer-related deaths in women in the United States. Black people in the United States also have the highest rates of colorectal cancer of any racial or ethnic group, according to the American Cancer Society.
Leading Cancer Treatment Recommendations from NCCN Now Available in French, German, Italian, Portuguese, Russian, and Spanish
NCCN Guidelines, containing expert recommendations for cancer care, are available in French, German, Italian, Portuguese, Russian, and Spanish can all be accessed for free at NCCN.org/global or via the free Virtual Library of NCCN Guidelines® App
Center for Asian Health Equity awarded $4.25 million CDC grant to prevent colorectal cancer in Illinois
The University of Chicago Medicine’s Center for Asian Health Equity has received a five-year, $4.25 million federal grant to increase colorectal cancer screenings, particularly among underserved and rural Illinois communities.
UCLA oncologist available to comment on changing landscape of colon cancer and the death of Chadwick Boseman
Oncologist Dr. Zev Wainberg, medical director of the UCLA Colorectal Cancer Center, is available to discuss the death of Chadwick Boseman and the changing landscape of colon cancer. Dr. Wainberg and his laboratory are developing and testing new targeted therapies for…
Is 43 Too Young for Colon Cancer? UC San Diego Health Experts Available to Talk About Colorectal Cancer
With the recent death of actor Chadwick Boseman, many may be wondering how a seemingly healthy adult is diagnosed with a disease often thought of as illness of older adults. Although colorectal cancer is most often diagnosed in people 50…
Ludwig Chicago Study Identifies a Novel Drug Target for the Control of Cancer Metastasis
Researchers led by Ludwig Chicago Co-director Ralph Weichselbaum and Ronald Rock of the University of Chicago have identified in preclinical studies a potential drug target for curtailing cancer metastasis.
Small Molecule Treatment Reduces Colon Cancer Metastasis
University of Chicago Medicine investigators have found a new way to slow the metastasis of colon cancer: by treating it with a small molecule that essentially locks up cancer cells’ ability to change shape and move throughout the body.
Road Map to Reducing Colorectal Cancer Deaths
According to the American Gastroenterological Association’s recently published “Roadmap for the Future of Colorectal Cancer Screening in the United States, ” fewer people would die of colorectal cancer if health care providers adopted a new model of screening that combines better risk assessment, more options for noninvasive testing and more targeted referrals for colonoscopies. Rush University Medical Center’s Joshua Melson, MD is lead author.
COVID-related Delays in Colorectal Cancer Screening Jeopardizes Preventive Care, Early Treatment
Cancer physicians are concerned that Covid-related delays could reverse important gains in preventing colorectal cancer
Study Shows Opioid, Sedative and Antidepressant Use Pre-Surgery Leads to Worse Outcomes
A study led by University of Kentucky Markey Cancer Center researchers showed that patients who already used opioids, sedatives or antidepressants prior to colorectal surgery experience significantly more complications post-surgery.
UK Study Finds Many Colon Cancer Patients Not Receiving Standard of Care Therapy
A new University of Kentucky Markey Cancer Center study finds that many Kentucky patients with colon cancer are not receiving the recommended standard of care therapy for their disease.
MSK: Cancer Isn’t Sheltering in Place
As the height of the COVID-19 outbreak in New York City and the Tri-State area begins to subside, Memorial Sloan Kettering Cancer Center oncologists are urging patients to schedule cancer screenings and treatments now – as the long-term toll of missed diagnoses and delayed treatments could be devastating for patients and their loved ones across the region and the country.
Finding from a Johns Hopkins study challenges the belief that robotic surgery provides a favorable alternative to open surgery in frail patients
Minimally invasive surgical techniques are routinely promoted as alternatives to open surgery because of improved outcomes. However, the impact of robotic surgery on certain subsets of the population, such as frail patients, is poorly understood. Although minimally invasive surgical approaches have…
Colorectal Cancer Q&A: The Truth about Screening, Prevention, and More
A colonoscopy is the best way to screen for and prevent colorectal cancer (CRC) because it allows your doctor to find and remove precancerous growths called polyps before they have a chance to turn into cancer.
The U.S. Preventive Services Task Force (USPSTF) recommends that most people have colonoscopy screenings starting at age 50. People who are at a higher risk for CRC due to family history or other factors should begin having screenings at a younger age based on their doctor’s recommendation.
Cologuard, an at-home test, is not a preventive CRC screening tool because it detects cancer after you develop it.
Study examines reasons why colon cancer is more deadly in pediatric and young adult patients than adults age 25 and over
Colon cancer is more likely to be lethal in children and young adults than middle-aged adults.
Researchers identify new therapeutic target for colorectal cancer
Researchers at the University of Toronto have identified a key protein that supports the growth of many colorectal cancers. The study, which will be published December 27 in the Journal of Cell Biology, reveals that a protein called Importin-11 transports the cancer-causing protein βcatenin into the nucleus of colon cancer cells, where it can drive cell proliferation. Inhibiting this transport step could block the growth of most colorectal cancers caused by elevated βcatenin levels.
Intestinal Stem Cell Genes May Link Dietary Fat and Colon Cancer
Two genes that appear to help stem cells in the intestine burn dietary fat may play a role in colon cancer, according to a Rutgers study. The study, published in the journal Gastroenterology, describes a new connection between the way cells consume fat and how genes regulate stem cell behavior in the intestines of mice.
American College of Gastroenterology Announces Winners of Fifth Annual SCOPY Awards
American College of Gastroenterology announces 2019 SCOPY Award winners (Service Award for Colorectal Cancer Outreach, Prevention, and Year-Round Excellence) to recognize the achievements of ACG members in their community engagement, education and awareness efforts for colorectal cancer prevention
Microbiome Provides New Clues to Determining Development of Colon Cancer
Findings showcasing a connection between bacteria in the microbiome and colon cancer, which may be used to screen younger populations at risk, were published in the journal Gastroenterology by researchers from the George Washington University.
Antibiotics exposure linked to increased colon cancer risk
In an extensive “data mining” analysis of British medical records, researchers at the Johns Hopkins Kimmel Cancer Center conclude that taking even a single course of antibiotics might boost—albeit slightly—the risk of developing colon cancer—but not rectal cancer—a decade later. The findings, reported in the August 20 issue of the journal Gut , highlight the need for judicious use of this broad category of drugs, which are frequently improperly or overprescribed, the report authors say.